title: Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious?
authors.affiliation: Department of Dermatology, Complejo Hospitalario Toledo (Toledo Hospital Complex), Toledo, Spain. anai.sanchezmoya@yahoo.es.
authors.forename: Ana Isobel
authors.initials: AI
authors.lastname: Sánchez-Moya
authors.forename: Esteban
authors.initials: E
authors.lastname: Dauden
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007538:Isoniazid / Q000008:administration & dosage* / Q000009:adverse effects; D055985:Latent Tuberculosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000995:Antitubercular Agents; D007166:Immunosuppressive Agents; D007538:Isoniazid